AGP Executive Report
Last update: 5 hours agoStroke Prevention: China approved Bayer’s asundexian after studies reported a 26% cut in recurrent stroke risk without added bleeding; US review is ongoing. Infectious Disease: A dengue outbreak at construction sites in Hainan has led to thousands of workers being quarantined. Health Research: Chinese researchers developed a nanoparticle treatment that combines antibacterial and tissue-regenerating effects against periodontitis, tested in rats. Healthy Aging: New national guidance aims to improve long-term care insurance payments, while researchers have developed a measure to assess older outpatients’ medical-visit needs. Air Quality: China’s tighter air standards could prevent more than 200,000 deaths, according to a recent estimate.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
